Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

KEY TRONIC CORP (KTCC)

  • Business News
  • May 05, 2026, 20:03 UTC
  • 1
  • 1 comments

Key Tronic Corporation Announces Results for the Third Quarter of Fiscal Year 2026

Market reaction Comment Full text

BJS RESTAURANTS INC (BJRI)

  • Business News
  • May 05, 2026, 20:03 UTC
  • 1
  • 1 comments

BJ’s Restaurants, Inc. Reports Fiscal First Quarter 2026 Results

Market reaction Comment Full text

REVOLVE GROUP, INC. (RVLV)

  • Business News
  • May 05, 2026, 20:03 UTC
  • 1
  • 1 comments

Revolve Group Announces First Quarter 2026 Financial Results

Market reaction Comment Full text

VEECO INSTRUMENTS INC (VECO)

  • Business News
  • May 05, 2026, 20:03 UTC
  • 1
  • 1 comments

Veeco Announces $250 Million+ in Equipment Orders for Manufacturing Indium Phosphide Lasers

Market reaction Comment Full text

LUMENTUM HOLDINGS INC. (LITE)

  • Business News
  • May 05, 2026, 20:03 UTC
  • 1
  • 1 comments

Lumentum Announces Third Quarter of Fiscal Year 2026 Financial Results

Market reaction Comment Full text

CREDIT ACCEPTANCE CORP (CACC)

  • Business News
  • May 05, 2026, 20:02 UTC
  • 1
  • 1 comments

Credit Acceptance Announces First Quarter 2026 Results

Market reaction Comment Full text

AGRIFY CORPORATION (RYM)

  • Business News
  • May 05, 2026, 20:02 UTC
  • 1
  • 1 comments

RYTHM, Inc. Reports First Quarter 2026 Results

Market reaction Comment Full text

VEECO INSTRUMENTS INC (VECO)

  • Business News
  • May 05, 2026, 20:02 UTC
  • 1
  • 1 comments

Veeco Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

Rigel Pharmaceuticals Inc (RIGL)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 0
  • 1 comments

Rigel Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

Avalo Therapeutics Inc. (AVTX)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 0
  • 1 comments

Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa

Market reaction Comment Full text
  • Previous
  • 268
  • 269
  • 270
  • 271
  • 272
  • Next

Search

News categories

  • Technical Exchange News(12354)
  • Event(6229)
  • SEC News(271822)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158053)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin